An investigation into the effectiveness of acupuncture in the treatment of psychosomatic symptoms and psychological distress - a double-blind randomised placebo controlled trial

ISRCTN ISRCTN18177749
DOI https://doi.org/10.1186/ISRCTN18177749
Secondary identifying numbers N/A
Submission date
23/01/2013
Registration date
30/12/2014
Last edited
02/06/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Signs and Symptoms
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Somatic complaints are physical complaints that can’t be explained medically. They are estimated to cost the NHS around £3.2 billion a year. Symptoms reported are both numerous and varied. They can include palpitations, chest pains, gastrointestinal problems (e.g. nausea, vomiting, diarrhoea), muscle and joint pains, headaches, feeling dizzy, loss of sex drive and problems with the menstrual cycle. Patients with somatic complaints often suffer from depression, anxiety or other mental health problems. They are often told that their symptoms are “all in their head”, which can lead to a worsening of their symptoms and a detrimental effect on their everyday life. There is a big demand for rigorous investigation into more therapeutically intense treatments (or interventions) for somatic complaints to help alleviate pressure on the NHS. The aim of this study is to find out whether Traditional Chinese Acupuncture (TCA) can help alleviate symptoms in patients with somatic complaints.

Who can participate?
Adults aged 18-65 that have medically unexplained physical symptoms

What does the study involve?
Patients are randomly allocated into one of two groups. Those in group 1 are given 5 sessions of TCA. Those in group 2 are given a “placebo” acupuncture treatment. A special device is used to ensure that neither the practitioner or patient knows whether the needles are penetrating the skin. Patients are asked to report on their symptoms and fill in a general heath questionnaire before they start their first acupuncture session, 5/6 weeks after they have had their 5 acupuncture sessions and then 2 months after their last acupuncture session. Patients in the placebo group are offered 5 free sessions of genuine acupuncture once the study is complete.

What are the possible benefits and risks of participating?
For participants who have not had acupuncture before, this can be an exciting experience and an opportunity to try something new that may potentially improve symptoms not responsive to other forms of treatment. The risks are low as acupuncture has been shown to be extremely safe when applied by a qualified practitioner. However, there is a small risk of local bruising/irritation to the site where the needles are applied.

Where is the study run from?
1. An acupuncture clinic based in Luton (UK)
2. Psychology department of the University of Bedfordshire (UK)

When is the study starting and how long is it expected to run for?
May 2013 to May 2014

Who is funding the study?
Research Centre for Applied Psychology (UK)

Who is the main contact?
Ashley Bennett

Contact information

Mr Ashley Bennett
Scientific

Department of Psychology
University of Bedfordshire
Park Square
Luton
LU1 3JU
United Kingdom

Study information

Study designSingle-centre randomised double-blind placebo-controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleTraditional chinese medicine (TCM), a solution to medically unexplained symptoms? A double-blind randomised control trial and the role of psychological attachment in TCM's therapeutic outcome
Study acronymN/A
Study objectivesTraditional Chinese acupuncture will show significantly greater reduction in unexplained symptoms when compared to a placebo.
Ethics approval(s)1. Research Centre for Applied Psychology ethics committee, 31/05/2013
2. University of Bedfordshire Research Ethics Committee, 06/09/2013, ref: UREC13
Health condition(s) or problem(s) studiedMedically unexplained symptoms are closely related to somatisation which are a set of any symptoms that have no organic explanation
InterventionThis two arm trial has a treatment arm, in which participants will be given traditional Chinese acupuncture and the placebo arm whereby participants will be given placebo acupuncture using the park sham acupuncture device (or similar).
Intervention typeOther
Primary outcome measure1. Bradford somatic inventory (BSI) (Mumford et al., 1991)
2. General Health Questionnaire (GHQ-12) (Goldberg, 1978)
All measures are self-report and are taken at three time points: one at baseline (just before they have their first acupuncture session), 5/6 weeks later post-treatment (immediately after their last acupuncture session) and finally at follow-up, which is 2 months after their last appointment
Secondary outcome measures1. Client – Therapist attachment (CATS) (Mallinckrodt et al., 1995)
2. General Attachment Questionnaire (Bartholomew & Horowitz, 1991)
All measures are self-report and are taken at three time points: one at baseline (just before they have their first acupuncture session), 5/6 weeks later post-treatment (immediately after their last acupuncture session) and finally at follow-up, which is 2 months after their last appointment
Overall study start date01/05/2013
Completion date01/05/2014

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants100
Key inclusion criteriaPatients who are deemed by independent assessor to have medically unexplained symptoms, between the ages of 18-65
Key exclusion criteria1. Those who have had more than 5 treatments of acupuncture in the past 12 months will be excluded.
2. Those with complex and possibly terminal prognoses will be excluded (e.g., cancer patients)
3. Anyone who has undergone any major surgery in the preceding 6 months prior to the start of the trial
4. Anyone who has a severe psychiatric diagnosis
Date of first enrolment01/05/2013
Date of final enrolment01/05/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

University of Bedfordshire
Luton
LU1 3JU
United Kingdom

Sponsor information

University of Bedfordshire
University/education

c/o Ashley Bennett
Department of Psychology
Park Square
Luton
LU1 3JU
England
United Kingdom

Website http://www.beds.ac.uk/
ROR logo "ROR" https://ror.org/0400avk24

Funders

Funder type

Research organisation

Research Centre for Applied Psychology (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

02/06/2017: No publications found, verifying study status with principal investigator.